Spencer Wing, the founder of Rafa Green, built his career in the advertising industry over the last 40 years. He has earned a professional reputation and financial independence. But his definition of success and happiness changed in an extreme way after two significant events.
The first was in 1998, when his wife was diagnosed with stage-4 cancer. Fortunately, with the help of healthcare supplements and medical technology, the cancer went into remission. In 2002, Spencer himself suffered a brain stroke. Amazingly he recovered within a week and regained all his facilities.
After these two events, Spencer felt that in the absence of sustainable health, wealth becomes meaningless. Even worse, the absence of health and finance would be a worse tragedy. A man may have numerous dreams, but a patient has only one dream, to be healed. A man diagnosed with ill health and is in a poor financial situation will be overwhelmed with despair and powerlessness.
In 2006, Spencer established an MLM company, Rafa Green Sdn Bhd not just for the sake of creation of wealth but for two greater purposes, to allow more people to live better and to provide a viable career path for people who wish to become financially independent. Spencer being aware of the future trends in the personal health care industry, searched for a leading biotechnology product that will put Rafa ahead in the MLM industry. The opportunity to realize his dreams arose when Spencer met LONNIX.
LONNIX is a subsidiary of KOTRA PHARMA GROUP, is one of the largest pharmaceuticals distributors in Southeast Asia. They are famous for its health care products and is a leading pharmaceutical manufacturer. KOTRA PHARMA GROUP is listed on Kuala Lumpur Stock Exchange, Main Board.
KOTRA PHARMA has a 50-year-old family-medical knowledge that includes Chinese medicine, Western medicine, pharmaceuticals and nutrition. In Thailand and Indonesia, the company operates research and development facilities. In Philippines the company operates a hospital with the local and national authorities.
LONNIX is the R&D arm for the KOTRA PHARMA Group and is a leading research and development company. LONNIX has advanced manufacturing equipment and quality control that exceeds the requirements set by the Ministry of Health for meeting international standards. Its plants are certified for Halal standards.
LONNIX has many decades of continuous research and development collaborations with domestic and foreign experts. They are actively engaged in developing and creating new formulation for commercial use.
Today, Rafa has repositioned itself as Rafa World. KPDNKK has approved our new Binary Marketing Plan. Rafa is ready to shake the market by working with leaders and distributors towards a better future with a promising career platform.
